Noriyuki Kishi, M.D., Ph.D. |
| Title |
Instructor |
| Phone |
(617) 726-9235 |
| Fax |
(617) 726-2310 |
| Email |
noriyuki_kishi@hms.harvard.edu |
| Location |
Massachusetts General Hospital- Main Campus
MGH-HMS Center for Nervous System Repair
50 Blossom Street, EDR-410
Boston, MA 02114 |
Research Overview
My research career goal is to contribute to the
understanding and treatment of human neurological
disease, especially neurodevelopmental and neurodegenerative
disease. Specifically, many neurodevelopmental and neurodegenerative
diseases are possible to diagnose, but currently
impossible to treat effectively. After I received
my M.D. degree at Keio University School of Medicine
in Tokyo, I entered the Ph.D. course at Osaka University
Graduate School of Medicine. While I spent my Ph.D.
course in Osaka, neural stem cell research had been
progressing rapidly. As I thought neural stem cell
approaches might provide a breakthrough for the treatment
of neurological diseases, I joined the Macklis lab
as a postdoctoral fellow in 2001.
My current research interests lie in the neurobiological
understanding of the role of the methyl-CpG binding
protein 2 (MECP2) in the central nervous system (CNS).
Rett syndrome is a neurodevelopmental disorder and
one of the causes of mental retardation and autistic
behavior primarily in girls, but also in a small
group of boys. In 1999, it was discovered that mutation
of MECP2 gene encoding a transcriptional repressor
on the X chromosome causes Rett syndrome. Although
it is evident that phenotypes of MECP2 mutant mice
and symptoms of Rett syndrome are attributable to
lack of the MECP2 gene in the CNS, there is little
neuropathological understanding of the abnormalities
in the CNS of MECP2-null mice as well as of patients
with Rett syndrome. Therefore, I am investigating
the neuropathological events in
MECP2-null mice using histological, molecular biological,
and cell culture techniques, hoping that my study
will not only add to our understanding of molecular
mechanisms of MECP2 and pathological mechanisms of
Rett syndrome, but will potentially contribute to
the development of future therapeutic strategies
for patients with Rett syndrome.
Key Recent Publications
- Kishi N, Macklis JD. MECP2 is progressively expressed
in post-migratory
neurons and is involved in neuronal maturation
rather than cell fate decisions. Mol Cell Neurosci
(2004) 27: 306-321.
- Kishi N, Macklis JD. Dissecting MECP2 function
in the CNS.
J Child Neurol (2005) 10:753-759.
- Kishi N, Macklis JD. "Neurogenesis in the
adult mammalian brain" (Japanese), Igaku-no-Ayumi
(2002) 201:313-317.
|